Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSouth32 Limited Regulatory News (S32)

Share Price Information for South32 Limited (S32)

Share Price is delayed by 15 minutes
Get Live Data
242.80    1.40 (0.58%)
Bid:
242.40
Ask:
243.00
Spread: 0.60 (0.248%)
Market Cap: £10.87b
S32 Live PriceLast checked at - London Stock Exchange

Intraday South32 Limited Share Chart

Climate Commitment and Capital Management Program

18 May 2021 07:04

RNS Number : 9693Y
South32 Limited
18 May 2021
 

18 May 2021

 

South32 Limited

(Incorporated in Australia under the Corporations Act 2001)

(ACN 093 732 597)

ASX / LSE / JSE Share Code: S32 ADR: SOUHYISIN: AU000000S320

south32.net

 

CLIMATE COMMITMENT AND CAPITAL MANAGEMENT PROGRAM INCREASE

South32 Limited (ASX, LSE, JSE: S32; ADR: SOUHY) (South32) will host a call with equity analysts and investors today to discuss our operational performance and strategy, including an increase to our capital management program by US$200M to US$1.88B and our intent to achieve a 50% reduction in Scope 1 and 2 operational emissions by FY35[1].

South32 Chief Executive Officer, Graham Kerr said "Our briefing provides an opportunity to update all of our stakeholders on the future of South32. We are sustainably reshaping our business for a low carbon future by increasing our exposure to base metals. We have set a new medium-term target to halve our operational emissions by 2035 and are investing in efficiency projects, applying low carbon design principles and evaluating carbon reduction technologies to achieve this goal.

"Demonstrating the continued strength of our operating and financial performance, as well as the positive outlook for our business, we are also announcing a further US$200 million to be returned to shareholders through our capital management program. This decision is supported by our strong balance sheet and disciplined approach to capital allocation, and will take total returns to shareholders by our capital management program to US$1.88 billion."

The following document has today been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

 

· South32 Limited - New Climate Commitment and Increase to Capital Management Program

 

Further information

Our emissions performance will be independently reviewed and reported as part of our annual reporting suite.  We are also considering the most appropriate way to incorporate performance measures in our remuneration framework that are directly linked to our response to climate change and the longer-term commitments we've made.

The US$200M increase in our capital management program leaves US$316M to be returned to shareholders by3 September 2021, initially by continuing our on-market share buy-back. The associated Appendix 3D is attached to this announcement.

Conference call

 

South32 will hold a conference call at 9.00 am Australian Western Standard Time the details of which are as follows:

 

Conference ID: 10014026

Please pre-register for this call at link.

 

Separately a video presentation will be made available on the South32 website, as well as a recording of the conference call following its completion (https://www.south32.net/investors-media/investor-centre/presentations-reports-speeches).

 

 

 

About South32

South32 is a globally diversified mining and metals company. Our purpose is to make a difference by developing natural resources, improving people's lives now and for generations to come. We are trusted by our owners and partners to realise the potential of their resources. We produce bauxite, alumina, aluminium, energy and metallurgical coal, manganese, nickel, silver, lead and zinc at our operations in Australia, Southern Africa and South America. With a focus on growing our base metals exposure, we also have two development options in North America and several partnerships with junior explorers around the world.

 

 

Further Information

 

 

 

 

 

Investor Relations

 

 

Alex Volante

T +61 8 9324 9029

M +61 403 328 408

E Alex.Volante@south32.net

Tom Gallop

T +61 8 9324 9030

M +61 439 353 948

E Tom.Gallop@south32.net

 

 

 

 

Media Relations

 

 

Rebecca Keenan

T +61 8 9324 9364

M +61 402 087 055

E Rebecca.Keenan@south32.net

Jenny White

T +44 20 7798 1773

M +44 7900 046 758

E Jenny.White@south32.net

 

 

Further information on South32 can be found at www.south32.net.

Approved for release by Nicole Duncan, Company SecretaryJSE Sponsor: UBS South Africa (Pty) Ltd18 May 2021

 

 

[1] Compared with FY21 Baseline. The baseline will be adjusted for any material acquisitions or divestments based on emissions at the time of the transaction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFEEESITLIL
Date   Source Headline
2nd Mar 20237:51 amRNSDaily Share Buy-Back Notice
1st Mar 20238:01 amRNSDaily Share Buy-Back Notice
1st Mar 20237:56 amRNSTotal Voting Rights
28th Feb 20238:29 amRNSDaily Share Buy-Back Notice
24th Feb 20238:21 amRNSDaily Share Buy-Back Notice
23rd Feb 20237:52 amRNSDaily Share Buy-Back Notice
22nd Feb 20238:29 amRNSDaily Share Buy-Back Notice
21st Feb 20237:54 amRNSDaily Share Buy-Back Notice
16th Feb 20237:00 amRNSH1 FY23 Results Announcement
16th Feb 20237:00 amRNSLead Team Changes
16th Feb 20237:00 amRNSNotification of Dividend
16th Feb 20237:00 amRNS2023 Half Year Financial Results Presentation
16th Feb 20237:00 amRNSChanges Relating to Buy-Back (Appendix 3D)
23rd Jan 20237:00 amRNSQuarterly Report December 2022
9th Jan 20238:34 amRNS2023 Calendar of Key Dates
6th Jan 20238:49 amRNSNotification of Securities
3rd Jan 20238:51 amRNSTotal Voting Rights
22nd Dec 20228:52 amRNSDaily Share Buy-Back Notice
21st Dec 20228:45 amRNSDaily Share Buy-Back Notice
20th Dec 20228:46 amRNSDaily Share Buy-Back Notice
16th Dec 20228:35 amRNSDaily Share Buy-Back Notice
14th Dec 20228:42 amRNSNotification of Securities
14th Dec 20228:31 amRNSDaily Share Buy-Back Notice
13th Dec 20228:56 amRNSDaily Share Buy-Back Notice
12th Dec 20229:28 amRNSNotification of Dealing Form
12th Dec 20229:07 amRNSDaily Share Buy-Back Notice
5th Dec 20229:37 amRNSSecurities Dealing Policy
2nd Dec 20228:30 amRNSDaily Share Buy-Back Notice
1st Dec 20227:59 amRNSTotal Voting Rights
30th Nov 20227:47 amRNSDaily Share Buy-Back Notice
25th Nov 20229:06 amRNSDaily Share Buy-Back Notice
23rd Nov 20228:20 amRNSDaily Share Buy-Back Notice
22nd Nov 20229:02 amRNSDaily Share Buy-Back Notice
21st Nov 20228:57 amRNSDaily Share Buy-Back Notice
17th Nov 20228:36 amRNSDaily Share Buy-Back Notice
11th Nov 20228:49 amRNSDaily Share Buy-Back Notice
10th Nov 20228:26 amRNSDaily Share Buy-Back Notice
9th Nov 20228:07 amRNSDaily Share Buy-Back Notice
4th Nov 20228:36 amRNSDaily Share Buy-Back Notice
2nd Nov 20228:01 amRNSDaily Share Buy-Back Notice
1st Nov 20228:06 amRNSDaily Share Buy-Back Notice
1st Nov 20228:00 amRNSTotal Voting Rights
31st Oct 20229:11 amRNSNotification of Dealing Form
31st Oct 20229:00 amRNSNotification of Securities
28th Oct 20229:14 amRNSDaily Share Buy-Back Notice
27th Oct 202210:33 amRNS2022 Annual General Meeting Results
27th Oct 20227:58 amRNSDaily Share Buy Back Notice
27th Oct 20227:28 amRNS2022 AGM - Chair and CEO Addresses
26th Oct 20228:03 amRNSDaily Share Buy-Back Notice
24th Oct 20227:00 amRNSQuarterly Report - September 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.